# Availability, prices and affordability of essential medicines in Chad, 2023

Source: https://onco.cc/key-papers/paper-ragomzingba-essential-medicines-chad-pamj-2025/  
OnCo record `paper-ragomzingba-essential-medicines-chad-pamj-2025` (Key paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A June to July 2023 survey using the WHO and Health Action International method found essential medicines in stock in 52.6% of public health facilities on average, with the lowest availability in Batha, Kanem, Lac and Hadjer Lamis.

## Summary

Published as "National availability, prices and affordability of essential medicines: a comprehensive analysis using WHO/HAI methodology in Chad". A descriptive cross-sectional study of public, private and contracted (religious) outlets, carried out from 1 June to 31 July 2023 by WHO's Chad office with staff of the General Directorate of Pharmacy, Medicines and Laboratories. Availability was the share of surveyed outlets holding each medicine, and prices were expressed as median price ratios. The introduction describes the regulatory system: the Directorate acts as the national regulator, the authors rate its maturity at level 1 on a scale of 1 to 4, and the country has no medicines manufacturer. It was the first such survey in Chad since 2004.

## Fields

- Kind: Key paper
- Last checked: 2026-11-11
- Journal: Pan African Medical Journal
- Year: 2025
- DOI: 10.11604/pamj.2025.51.72.47698
- Authors: Ragomzingba FEZ, Haroun SH, Ngabéré C, et al.
- Findings: Average availability across all public health institutions was 52.6%, from roughly 46% at health centres to 61.4% at provincial supply pharmacies.; In the private sector availability was around 38% at wholesalers, 48% at pharmacies and 58.4% at pharmaceutical depots; the contracted sector was 48%.; Batha, Kanem, Lac and Hadjer Lamis had the lowest availability, between 39 and 43%; the lowest-priced generics cost 9 times less than originator brands in the contracted sector, 4 times less in the public sector and 2 times less in the private sector.
- What it means: The survey covers essential medicines in general, not cancer medicines, but it shows the supply system cancer care in Chad depends on: about half of listed medicines in stock in public facilities, and generics far cheaper than brands.
- Caveats: Convenience sampling of outlets.; Not specific to cancer medicines; the abstract gives no figure for any cancer drug.

## Sources

- Pan Afr Med J 2025: https://doi.org/10.11604/pamj.2025.51.72.47698
- PubMed: https://pubmed.ncbi.nlm.nih.gov/41064686/
- Full text (PDF, WHO Africa): https://afro.who.int/sites/default/files/2025-10/Article%20Dispo%26Prix%20Med_Chad%20PAMJ%202025.pdf

## Connected records

- institutions: [General Directorate of Pharmacy, Medicines and Laboratories, Chad (DGPML)](https://onco.cc/institutions/dgpml-chad/), [Ministry of Public Health and Prevention, Chad](https://onco.cc/institutions/chad-ministry-of-public-health/), [World Health Organization Cancer Programme](https://onco.cc/institutions/who/)

---
JSON: https://onco.cc/api/v1/entities/paper-ragomzingba-essential-medicines-chad-pamj-2025.json